2026 Future Talent Program - Agentic AI - Co-Op jobs in United States
cer-icon
Apply on Employer Site
company-logo

Merck · 3 hours ago

2026 Future Talent Program - Agentic AI - Co-Op

Merck is a leading company in the pharmaceutical industry, and they are seeking a motivated Co-op student to join their Computational Toxicology team. This role involves applying machine learning and natural language processing to enhance drug safety assessments and develop AI pipelines that integrate various toxicology datasets.

BiotechnologyHealth CareMedicalPharmaceutical
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Develop and evaluate predictive models to assess compound safety risks and identify toxicity mechanisms using multimodal pharmaceutical data
Design and implement NLP/LLM pipelines (prompt engineering, fine-tuning, retrieval-augmented generation, etc.) to extract insights from unstructured reports and biomedical literature
Build and deploy interactive dashboards (e.g., Streamlit, Dash) to visualize and communicate findings to toxicologists, chemists, and project teams
Collaborate with multidisciplinary scientists across toxicology, chemistry, and data science to translate computational outputs into actionable safety insights

Qualification

NLP frameworksLLM techniquesPython programmingData wranglingModel developmentGit/GitHubPassion for AICollaboration

Required

Currently pursuing a Ph.D. in Computational Science, Data Science, Bioinformatics, Computational Biology/Chemistry, Computational Linguistics, or a related field
Experienced with NLP and LLM frameworks (e.g., Hugging Face, spaCy, NLTK) and techniques such as prompt design, fine-tuning, and retrieval-augmented generation (RAG)
Proficient in Python, with strong skills in statistics, data wrangling (pandas/SQL), and model development (scikit-learn, PyTorch, TensorFlow)
Familiar with Git/GitHub workflows
Passionate about applying AI to improve human safety, reduce animal testing, and transform decision-making in drug discovery

Company

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Funding

Current Stage
Public Company
Total Funding
$5.59M
Key Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO

Leadership Team

leader-logo
Betty Larson
Executive Vice President and Chief Human Resources Officer
linkedin
leader-logo
Dean Li
Executive Vice President and President, Merck Research Laboratories
linkedin
Company data provided by crunchbase